GO:1902914 regulation of protein polyubiquitination: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902914 (regulation of protein polyubiquitination) is a biological process that modulates the frequency, rate, or extent of attaching polyubiquitin chains to target proteins [1, 5].
• Polyubiquitination is a post-translational modification where multiple ubiquitin molecules form chains on a substrate, influencing protein stability, localization, and interactions [2, 5].
• Different ubiquitin chain linkages (e.g., K27, K63, K48) dictate distinct functional outcomes, from immune signaling to proteasomal degradation [3, 6, 8].
• Regulation occurs at multiple levels: E3 ligases, deubiquitinases (DUBs), ubiquitin-binding domains, and substrate modification states [5, 7].
• Dysregulation of polyubiquitination is linked to cancer, neurodegenerative diseases, and immune disorders, making it a therapeutic target [3, 6, 8].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential to dissect causal roles of specific regulators in polyubiquitination pathways [4, 7].
Description
Protein polyubiquitination is a fundamental post-translational modification in which multiple ubiquitin molecules are covalently attached to a target protein, forming a polyubiquitin chain [2, 5]. This process is dynamically regulated by a coordinated network of enzymes, including E1 activating enzymes, E2 conjugating enzymes, E3 ligases, and deubiquitinases (DUBs), as well as ubiquitin-binding proteins that interpret the chain code. The Gene Ontology term GO:1902914, regulation of protein polyubiquitination, encompasses any process that modulates the frequency, rate, or extent of this modification. Understanding this regulation is critical because polyubiquitination controls protein degradation, trafficking, DNA repair, immune signaling, and cell cycle progression [3, 7, 8]. Research has revealed that polyubiquitination is not a uniform signal; the type of linkage (e.g., K48, K63, K27) determines the fate of the modified protein [3, 6, 8]. For instance, K48-linked chains typically target proteins for proteasomal degradation, while K63-linked chains often mediate non-degradative functions such as signal transduction and DNA damage tolerance. The regulation of these processes is highly context-dependent and involves crosstalk with other modifications, such as monoubiquitination and phosphorylation. Given its broad impact, dysregulation of polyubiquitination is implicated in numerous human diseases, including cancer, neurodegeneration, and immune deficiencies [3, 6, 8]. Therefore, studying the regulators of polyubiquitination is essential for understanding disease mechanisms and developing targeted therapies. This article provides a comprehensive overview of GO:1902914, covering its definition, mechanisms, key genes, research methods, and the CRISPR models available to investigate it.
regulation of protein polyubiquitination At A Glance
| GO ID | GO:1902914 |
|---|---|
| GO term | regulation of protein polyubiquitination |
| Ontology | biological_process |
| Synonym | regulation of polyubiquitin; regulation of protein polyubiquitinylation; regulation of protein polyubiquitylation |
| Major function | Modulates the addition of polyubiquitin chains to target proteins, influencing their stability, localization, and interactions. |
| Related processes | Protein degradation, DNA repair, immune signaling, cell cycle regulation |
| Key enzymes | E1, E2, E3 ligases, deubiquitinases (DUBs) |
| Subcellular location | Cytoplasm, nucleus, proteasome |
| Disease relevance | Cancer, neurodegenerative disorders, immune dysregulation |
What Is GO:1902914?
GO:1902914, regulation of protein polyubiquitination, is defined as any process that modulates the frequency, rate, or extent of protein polyubiquitination. In simpler terms, it includes all the cellular mechanisms that control how much and how often polyubiquitin chains are added to proteins. This regulation can occur at the level of enzyme activity (e.g., E3 ligases and DUBs), substrate availability, or the recognition of ubiquitin chains by effector proteins [1, 5].
Why Is regulation of protein polyubiquitination Important in Cell Biology?
Regulation of protein polyubiquitination is crucial because it governs the fate of numerous proteins involved in essential cellular processes. By controlling polyubiquitination, cells can rapidly respond to stress, regulate cell cycle progression, and maintain protein homeostasis [2, 5]. Dysregulation of this process leads to accumulation of damaged proteins, aberrant signaling, and disease. For example, impaired polyubiquitination of the proteasome can lead to its aggregation, as seen in stress conditions. Moreover, specific polyubiquitin linkages are critical for immune responses, such as K27-linked polyubiquitination of TRIF in innate immunity. Thus, understanding the regulation of polyubiquitination offers insights into basic biology and therapeutic opportunities.
• Controls protein degradation via the ubiquitin-proteasome system, essential for cellular homeostasis.
• Regulates immune signaling pathways, including TRIF-mediated innate immunity.
• Modulates DNA damage tolerance through PCNA polyubiquitination.
• Influences plant cold stress responses via ICE1 stability.
• Affects ion channel surface expression, such as KCNQ1.
• Involved in phase separation of the proteasome under stress.
• Dysregulation linked to cancer, neurodegeneration, and immune disorders [3, 6, 8].
• Provides targets for therapeutic intervention, e.g., DUB inhibitors.
• Essential for understanding ubiquitin code specificity and crosstalk [5, 7].
• Enables development of CRISPR models to study causal roles of regulators [4, 7].
What Happens During regulation of protein polyubiquitination?
Initiation: Activation and Conjugation of Ubiquitin
In simple terms: First, ubiquitin is activated and attached to a target protein.
The process begins with the ATP-dependent activation of ubiquitin by an E1 enzyme, followed by transfer to an E2 conjugating enzyme. The E2 then collaborates with an E3 ligase to attach ubiquitin to a lysine residue on the substrate. This initial monoubiquitination is a prerequisite for polyubiquitin chain formation [2, 5]. Regulation at this step includes the availability of E1, E2, and E3 enzymes, as well as substrate accessibility.
Chain Elongation and Linkage Specificity
In simple terms: Additional ubiquitin molecules are added to form a chain, and the type of linkage determines the signal.
Polyubiquitin chains are formed by the sequential addition of ubiquitin moieties to one of seven lysine residues (K6, K11, K27, K29, K33, K48, K63) or the N-terminal methionine (M1) of the previous ubiquitin. The specific linkage is determined by the E2-E3 pair and can be further edited by DUBs [5, 8]. For example, K27-linked polyubiquitination regulates TRIF-mediated immune signaling, while K63-linked chains are involved in proteasome-independent functions in plants. Linkage specificity is crucial for downstream outcomes.
Recognition and Effector Functions
In simple terms: Proteins with ubiquitin-binding domains read the chain and trigger specific cellular responses.
Once formed, polyubiquitin chains are recognized by ubiquitin-binding domains (UBDs) in effector proteins. These interactions can lead to proteasomal degradation (e.g., K48-linked chains), endocytosis, DNA repair, or signal transduction. For instance, the proteasome recognizes K48-linked chains, but under stress, ubiquitin chains can drive phase separation of the proteasome. The regulation of polyubiquitination thus extends to the availability and activity of these reader proteins.
Deubiquitination: Reversal and Editing
In simple terms: Deubiquitinases remove or trim ubiquitin chains, providing a dynamic balance.
Deubiquitinases (DUBs) are proteases that cleave ubiquitin chains, reversing or editing the modification. They can remove entire chains or specific linkages, thereby regulating the stability and function of substrates [3, 6]. For example, DUBs regulate KCNQ1 surface expression by removing specific polyubiquitin chains. The interplay between E3 ligases and DUBs determines the net level of polyubiquitination, making DUBs key regulators of GO:1902914 [5, 6].
Crosstalk with Other Modifications
In simple terms: Polyubiquitination can be influenced by other modifications like phosphorylation or monoubiquitination.
Regulation of polyubiquitination often involves crosstalk with other post-translational modifications. For instance, PCNA monoubiquitination levels determine whether polyubiquitination occurs, influencing the choice of DNA damage tolerance pathway. Similarly, phosphorylation of substrates can create or destroy recognition sites for E3 ligases, thereby modulating polyubiquitination. This crosstalk adds another layer of regulation to GO:1902914.
Key Genes Involved in GO:1902914 regulation of protein polyubiquitination
The following genes and proteins are key players in the regulation of protein polyubiquitination, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| UBB | Ubiquitin precursor | Source of ubiquitin for polyubiquitination; knockout lethal in many organisms. |
| UBC | Ubiquitin precursor | Provides ubiquitin; involved in stress responses. |
| TRIF (TICAM1) | Adaptor in TLR signaling | K27-linked polyubiquitination regulates innate immune response. |
| PUB25 | E3 ligase | Modulates ICE1 stability via differential ubiquitination in cold stress. |
| PUB26 | E3 ligase | Modulates ICE1 stability via differential ubiquitination in cold stress. |
| ICE1 | Transcription factor | Regulated by PUB25/PUB26; key in cold acclimation. |
| KCNQ1 | Potassium channel | Surface expression regulated by polyubiquitination. |
| HLTF | E3 ligase | Mediates PCNA polyubiquitination for DNA damage tolerance. |
| PCNA | DNA sliding clamp | Polyubiquitination determines damage tolerance pathway. |
| RFC | Clamp loader | Regulates HLTF-mediated PCNA polyubiquitination. |
| RPN10 | Proteasome subunit | Ubiquitin receptor; involved in phase separation. |
| RPN13 | Proteasome subunit | Ubiquitin receptor; involved in phase separation. |
| UCHL5 | Deubiquitinase | Associated with proteasome; regulates polyubiquitination. |
| USP14 | Deubiquitinase | Associated with proteasome; regulates polyubiquitination. |
| TRIM25 | E3 ligase | Example of E3 ligase in immune signaling (implied by). |
| CYLD | Deubiquitinase | Regulates K27-linked polyubiquitination of TRIF. |
| A20 (TNFAIP3) | Deubiquitinase | Regulates immune signaling via polyubiquitin editing. |
| UBQLN2 | Ubiquitin-binding protein | Implicated in neurodegeneration; binds polyubiquitin. |
How Is regulation of protein polyubiquitination Regulated?
The regulation of protein polyubiquitination is itself tightly controlled at multiple levels. E3 ligases are regulated by phosphorylation, subcellular localization, and autoinhibition. DUBs counteract E3 activity and are also subject to regulation. Ubiquitin-binding proteins can sequester or present chains to effectors. Additionally, the availability of ubiquitin and the activity of E1/E2 enzymes influence the overall rate. Crosstalk with other modifications, such as phosphorylation and monoubiquitination, provides additional layers of control. For example, in Arabidopsis, PUB25 and PUB26 dynamically modulate ICE1 stability via differential ubiquitination during cold stress. In the immune system, K27-linked polyubiquitination of TRIF is balanced by deubiquitinases to prevent excessive inflammation.
regulation of protein polyubiquitination and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TRIF (TICAM1) | Innate immune signaling; autoinflammation | Knockout or point mutation in macrophages |
| KCNQ1 | Long QT syndrome; cardiac arrhythmia | Knock-in of ubiquitination-deficient mutant in cardiomyocytes |
| PCNA | DNA damage tolerance; cancer predisposition | Point mutation of ubiquitination sites in cancer cell lines |
| UBQLN2 | Amyotrophic lateral sclerosis (ALS) | Overexpression of mutant UBQLN2 in neurons |
| ICE1 | Cold stress response in plants | Knockout of PUB25/PUB26 in Arabidopsis |
Cancer
Dysregulation of polyubiquitination is frequently observed in cancer. For instance, altered expression or mutation of E3 ligases and DUBs can lead to stabilization of oncoproteins or degradation of tumor suppressors [5, 8]. K63-linked polyubiquitination, which regulates DNA damage tolerance, is critical for maintaining genomic stability; its impairment can contribute to cancer development [7, 8]. Targeting DUBs such as USP14 has emerged as a therapeutic strategy in oncology.
Neurodegenerative Diseases
Impaired protein degradation via the ubiquitin-proteasome system is a hallmark of neurodegenerative diseases like Alzheimer's and Parkinson's. Polyubiquitination regulates the clearance of misfolded proteins, and its dysfunction leads to protein aggregation [2, 5]. For example, stress-induced phase separation of the proteasome, dependent on polyubiquitin chains, may be relevant to neuronal stress responses. Mutations in ubiquitin-binding proteins such as UBQLN2 are linked to ALS.
Immune Disorders
Polyubiquitination is essential for innate and adaptive immunity. K27-linked polyubiquitination of TRIF is required for TLR signaling, and its dysregulation can lead to immunodeficiency or autoinflammation. Deubiquitinases like CYLD and A20 negatively regulate these pathways, and their mutations are associated with immune disorders. Thus, regulation of polyubiquitination is a key determinant of immune homeostasis.
From regulation of protein polyubiquitination-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of an E3 ligase affect substrate polyubiquitination? | Knockout of the E3 ligase gene using CRISPR |
| Does a specific ubiquitination site on the substrate mediate its function? | Point mutation of the lysine to arginine (K-to-R) via CRISPR |
| Does a disease-associated mutation in a DUB alter polyubiquitination? | Knock-in of the mutant allele using CRISPR |
| Can we track polyubiquitination dynamics in live cells? | Tagged knock-in of the substrate with a fluorescent protein |
| Does overexpression of a DUB reduce polyubiquitin chains? | Overexpression of the DUB via lentiviral transduction |
| What is the role of a ubiquitin-binding domain in effector function? | Knockout of the domain or point mutation of the binding interface |
How to Study the regulation of protein polyubiquitination Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry | Ubiquitination sites and chain linkages | Global profiling of polyubiquitination |
| Immunoblotting with linkage-specific antibodies | Levels of specific polyubiquitin chains | Validation of E3/DUB effects |
| Tandem ubiquitin-binding entities (TUBEs) | Enrichment of polyubiquitinated proteins | Detection of endogenous polyubiquitination |
| Fluorescence microscopy | Localization and dynamics of polyubiquitin | Live-cell imaging of proteasome phase separation |
| CRISPR knockout screens | Identification of genes regulating polyubiquitination | Discovery of novel regulators |
| In vitro ubiquitination assays | Enzymatic activity of E3 ligases | Mechanistic studies of chain formation |
| Proximity ligation assay (PLA) | Interaction between substrate and ubiquitin | Detection of polyubiquitination in situ |
| RNA-seq | Transcriptional changes upon perturbation | Assessing downstream effects of polyubiquitination |
Mass Spectrometry-Based Proteomics
Mass spectrometry can identify ubiquitination sites and quantify polyubiquitin chain linkages on a global scale. This method is used to map changes in polyubiquitination upon genetic perturbation or drug treatment [5, 7].
Ubiquitin Chain Enrichment and Immunoblotting
Using linkage-specific antibodies or ubiquitin-binding domains (e.g., TUBEs), researchers can enrich polyubiquitinated proteins and detect them by immunoblotting. This is a standard method to assess changes in polyubiquitination levels [3, 6].
Fluorescence Microscopy and Imaging
Live-cell imaging of fluorescently tagged ubiquitin or substrates allows visualization of polyubiquitination dynamics and subcellular localization. For example, phase separation of the proteasome can be observed by microscopy.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify regulators of polyubiquitination. For instance, a screen for modulators of PCNA polyubiquitination could reveal new components.
How CRISPR Can Be Used to Study GO:1902914 regulation of protein polyubiquitination
Knockout
CRISPR knockout of E3 ligases or DUBs can abolish or stabilize polyubiquitination of specific substrates, revealing their functional importance. For example, knockout of PUB25 and PUB26 in Arabidopsis affects ICE1 stability and cold tolerance. In human cells, knockout of HLTF impairs PCNA polyubiquitination and DNA damage tolerance.
Point Mutation
Introducing point mutations (e.g., K-to-R) at ubiquitination sites on a substrate using CRISPR can prevent polyubiquitination without affecting other functions. This approach has been used to study PCNA polyubiquitination and its role in damage tolerance. Similarly, point mutations in DUBs can inactivate their catalytic activity.
Knock-in
Knock-in of disease-associated mutations or tagged versions of genes allows study of polyubiquitination in a physiological context. For instance, knocking in a fluorescent tag on a substrate enables live-cell imaging of its polyubiquitination. Knock-in of mutant KCNQ1 can reveal how polyubiquitination regulates channel surface expression.
Overexpression
Overexpression of E3 ligases or DUBs via CRISPR activation or lentiviral delivery can enhance or reduce polyubiquitination levels, respectively. This is useful to test sufficiency of a regulator. For example, overexpression of a DUB can reduce polyubiquitin chains on KCNQ1.
How EDITGENE Supports regulation of protein polyubiquitination Research
Researchers studying regulation of protein polyubiquitination-related genes often need to determine whether a candidate gene is causally involved in the process, and which specific ubiquitination sites or domains mediate its function. EDITGENE provides a comprehensive suite of CRISPR services to address these questions, from generating knockout cell lines to precise point mutations and knock-ins, as well as library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for regulation of protein polyubiquitination research.
Frequently Asked Questions About regulation of protein polyubiquitination
What is regulation of protein polyubiquitination?
It is the biological process that modulates the frequency, rate, or extent of attaching polyubiquitin chains to proteins, as defined by GO:1902914.
What genes are involved in regulation of protein polyubiquitination?
Key genes include E3 ligases (e.g., PUB25, PUB26, HLTF), deubiquitinases (e.g., CYLD, USP14), and substrates like PCNA and ICE1 [3, 4, 6, 7].
How does polyubiquitination regulate protein function?
Polyubiquitin chains can target proteins for degradation, alter their localization, or mediate signaling, depending on the linkage type [2, 5, 8].
What are the different types of polyubiquitin chains?
Chains can be linked through lysine 48 (K48), K63, K27, K11, etc., each associated with distinct cellular outcomes [3, 6, 8].
What diseases are linked to dysregulation of polyubiquitination?
Cancer, neurodegenerative diseases, and immune disorders are associated with defects in polyubiquitination [3, 5, 6].
How can CRISPR be used to study regulation of protein polyubiquitination?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of genes involved in polyubiquitination [4, 7].
What methods are used to measure polyubiquitination?
Mass spectrometry, immunoblotting with linkage-specific antibodies, TUBEs, and fluorescence microscopy are commonly used [1, 3, 5, 6].
What is the role of deubiquitinases in polyubiquitination?
DUBs remove or edit ubiquitin chains, counteracting E3 ligases and providing dynamic regulation [3, 6].
Can polyubiquitination occur independently of the proteasome?
Yes, K63-linked polyubiquitination often mediates proteasome-independent functions such as DNA repair and signaling.
How does stress affect polyubiquitination?
Stress can induce phase separation of the proteasome via ubiquitin chains, as seen in stress-dependent responses.
Conclusion
Regulation of protein polyubiquitination (GO:1902914) is a central process in cellular physiology, controlling protein fate and signaling. Its dysregulation underlies numerous diseases, making it a prime target for therapeutic intervention. Advances in CRISPR technology and proteomic methods continue to unravel the complex regulatory networks, offering new opportunities for drug discovery. EDITGENE's suite of CRISPR services empowers researchers to dissect these mechanisms with precision.
References
- 1. Yasuda S et al.. 2020. Stress- and ubiquitylation-dependent phase separation of the proteasome.. Nature 578(7794):296-300 PMID: 32025036
- 2. Dahlmann B. 2005. Proteasomes.. Essays Biochem 41:31-48 PMID: 16250896
- 3. Wu X et al.. 2019. Regulation of TRIF-mediated innate immune response by K27-linked polyubiquitination and deubiquitination.. Nat Commun 10(1):4115 PMID: 31511519
- 4. Wang X et al.. 2023. PUB25 and PUB26 dynamically modulate ICE1 stability via differential ubiquitination during cold stress in Arabidopsis.. Plant Cell 35(9):3585-3603 PMID: 37279565
- 5. Hurley JH et al.. 2006. Ubiquitin-binding domains.. Biochem J 399(3):361-72 PMID: 17034365
- 6. Shanmugam SK et al.. 2025. Decoding polyubiquitin regulation of K(V)7. 1 (KCNQ1) surface expression with engineered linkage-selective deubiquitinases.. Nat Commun 16(1):5805 PMID: 40593673
- 7. Masuda Y et al.. 2018. Regulation of HLTF-mediated PCNA polyubiquitination by RFC and PCNA monoubiquitination levels determines choice of damage tolerance pathway.. Nucleic Acids Res 46(21):11340-11356 PMID: 30335157
- 8. Romero-Barrios N et al.. 2018. Proteasome-independent functions of lysine-63 polyubiquitination in plants.. New Phytol 217(3):995-1011 PMID: 29194634
